|
|
||||||||
From the Obstetrical and Gynecological Group, Perth Amboy, NJ.
Abstract
The administration of meprobamate during one or more trimesters of pregnancy to nearly 800 women because of some anxiety-evoked symptom enabled comparison of pregnancy outcome with that of more than 5000 other gravidas from the same private practice. No deleterious effect upon the pregnancy or fetus was observed in the meprobamate-treated group; the ratios to normal births of congenital abnormality, prematurity, stillbirth, and abortion were unaffected by the meprobamate.
This article has been cited by other articles:
![]() |
G Timmermann, N Acs, F Banhidy, and A. Czeizel A study of teratogenic and fetotoxic effects of large doses of meprobamate used for a suicide attempt by 42 pregnant women Toxicology and Industrial Health, February 1, 2008; 24(1-2): 97 - 107. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |